A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses

Download

Preininger MK, Jha R, Maxwell JT, Wu Q, Singh M, Wang B, Dalal A, Mceachin ZT, Rossoll W, Hales CM, Fischbach PS, Wagner MB, Xu C.

Dis Model Mech, 2016

Related Resources
Patient specific Long QT syndrome type 3 cardiomyocytes can be used for clinical drug safety assessments
Inter-individual differences in electrophysiology, pharmacology and drug responses in a cohort of hiPSC-derived cardiomyocytes: Endorsing clinical trials-in-a-dish
Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization
Sex-related differences in drug-induced QT prolongation and Torsades de Pointes: a new model system with human iPSC-CMs

Related Products

Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Learn more >>
Axion BioSystems Cardiac software Module for MEA experiments